One of the nation’s largest banks discriminates against black, Latino and Asian homebuyers by offering lesser qualified white borrowers higher loan amounts and using hidden racial criteria in one of its loan programs, according to a lawsuit filed this week in federal court in Manhattan. The suit also accuses the bank of steering homebuyers to certain neighborhoods based on their race or ethnicity.Full Story»
This week, the U.S. Supreme Court will take up one of the most important civil rights cases of the last decade when it considers the case of Texas Department of Housing and Community Affairs v. The Inclusive Communities Project. The case concerns whether the Fair Housing Act, which sought to end the longstanding segregation of America’s neighborhoods, should be read to only bar intentional discrimination. For four decades, federal courts have held that the law should be interpreted more broadly.
An investigation by ProPublica examines information from a database known as Open Payments, which gives the first comprehensive look at how much money drug and device companies have spent working with doctors. What it shows is that the drugs most aggressively promoted to doctors typically aren’t cures or even big medical breakthroughs. Some are top sellers, but most are not.
As the Federal Reserve Bank of New York moved to beef up its oversight of Wall Street two years ago, the team charged with supervising the nation’s largest bank, JPMorgan Chase, was in turmoil. Fed examiners embedded at JPMorgan complained about being blocked from doing their jobs. In frustration, some requested transfers.
More in this category
- California Governor Signs Bill to Protect Temp Workers
- Inside the New York Fed: Secret Recordings and a Culture Clash
- Geithner Book: ‘I Should Have Paid More Attention’ to Citigroup’s Woes
- Power Tool Makers Accused of Thwarting Adoption of Finger-Saving Device
- Stunning Loss for Lead Paint Makers in California Lawsuit
- GlaxoSmithKline to Quit Paying Doctors for Promotional Talks